SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-031917
Filing Date
2019-06-21
Accepted
2019-06-21 17:01:22
Documents
1
Period of Report
2019-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv524055_4.html 4  
1 OWNERSHIP DOCUMENT tv524055_4.xml 4 3919
  Complete submission text file 0001144204-19-031917.txt   5393
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Ren Ken Keyong (Reporting) CIK: 0001545181 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20713 | Film No.: 19912247